BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30955261)

  • 1. [Diagnosis of lung biopsy employing the 2015 WHO criteria and detection of related oncogenic driver mutations].
    Fang F; Qiao XB; Yang L; Di J; Hu ST; Liu DG; Lyu N
    Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):270-275. PubMed ID: 30955261
    [No Abstract]   [Full Text] [Related]  

  • 2. ROS1 fusions in Chinese patients with non-small-cell lung cancer.
    Cai W; Li X; Su C; Fan L; Zheng L; Fei K; Zhou C; Manegold C; Schmid-Bindert G
    Ann Oncol; 2013 Jul; 24(7):1822-1827. PubMed ID: 23514723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis.
    Kadota K; Nitadori J; Rekhtman N; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2015 Sep; 39(9):1170-80. PubMed ID: 25871623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of mixed pulmonary carcinoma and carcinoid: the driver from their mono-clonal origin.
    Graziano P; Parente P; Centra F; Milione M; Centonze G; Volante M; Cavazza A; Urbano D; Di Maggio G; Balsamo T; Di Micco C; Rossi G; Rossi A; Muscarella LA
    Virchows Arch; 2024 Jan; 484(1):37-46. PubMed ID: 37773451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker Testing in Patients With Unresectable Advanced or Recurrent Non-Small Cell Lung Cancer.
    Sakamoto T; Matsubara T; Takahama T; Yokoyama T; Nakamura A; Tokito T; Okamoto T; Akamatsu H; Oki M; Sato Y; Tobino K; Ikeda S; Mori M; Mimura C; Maeno K; Miura S; Harada T; Nishimura K; Hiraoka M; Kenmotsu H; Fujimoto J; Shimokawa M; Yamamoto N; Nakagawa K
    JAMA Netw Open; 2023 Dec; 6(12):e2347700. PubMed ID: 38100106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Small Cell Lung Cancer: Targetable Variants in Concurrent Tissue and Liquid Biopsy Testing in a North Indian Cohort.
    Paturu R; Lingaiah R; Kumari N; Singh S; Krishnani N; Srivastava S; Siddiqui SH; Nath A
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3467-3475. PubMed ID: 37898852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2021 WHO Classification of Lung Cancer: Molecular Biology Research and Radiologic-Pathologic Correlation.
    Sasaki T; Kuno H; Hiyama T; Oda S; Masuoka S; Miyasaka Y; Taki T; Nagasaki Y; Ohtani-Kim SJ; Ishii G; Kaku S; Shroff GS; Kobayashi T
    Radiographics; 2024 Mar; 44(3):e230136. PubMed ID: 38358935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of p53 gene mutation characteristics in lung carcinoma with special reference to histological subtypes.
    Fujita T; Kiyama M; Tomizawa Y; Kohno T; Yokota J
    Int J Oncol; 1999 Nov; 15(5):927-34. PubMed ID: 10536175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonality analysis of different histological components in combined small cell and non-small cell carcinoma of the lung.
    Murase T; Takino H; Shimizu S; Inagaki H; Tateyama H; Takahashi E; Matsuda H; Eimoto T
    Hum Pathol; 2003 Nov; 34(11):1178-84. PubMed ID: 14652820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors.
    Kobayashi Y; Tokuchi Y; Hashimoto T; Hayashi M; Nishimura H; Ishikawa Y; Nakagawa K; Sato Y; Takahashi A; Tsuchiya E
    Cancer Sci; 2004 Apr; 95(4):334-41. PubMed ID: 15072592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of high-grade pulmonary neuroendocrine carcinoma by fine-needle aspiration biopsy: nonsmall-cell or small-cell type?
    Yang YJ; Steele CT; Ou XL; Snyder KP; Kohman LJ
    Diagn Cytopathol; 2001 Nov; 25(5):292-300. PubMed ID: 11747218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens.
    Nicholson SA; Beasley MB; Brambilla E; Hasleton PS; Colby TV; Sheppard MN; Falk R; Travis WD
    Am J Surg Pathol; 2002 Sep; 26(9):1184-97. PubMed ID: 12218575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case of ROS1-Fusion Non-Small Cell Lung Cancer with Acquired BRAF Mutation Developing Unusual Skin Metastasis.
    Firoz WA; Sen F; Kiuru M; Huang V; Riess JW
    Clin Lung Cancer; 2024 Jun; 25(4):380-383. PubMed ID: 38429142
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung.
    Fukui T; Tsuta K; Furuta K; Watanabe S; Asamura H; Ohe Y; Maeshima AM; Shibata T; Masuda N; Matsuno Y
    Cancer Sci; 2007 Nov; 98(11):1714-9. PubMed ID: 17784875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinicopathological features of SMARCA4-deficient lung adenocarcinoma: a study of 42 cases].
    Han J; Gao XZ; Xu Y; Liu EJ; Du Q; Chen K; Li SL
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):136-142. PubMed ID: 38281780
    [No Abstract]   [Full Text] [Related]  

  • 16. Bio-Inspired NanoVilli Chips for Enhanced Capture of Tumor-Derived Extracellular Vesicles: Toward Non-Invasive Detection of Gene Alterations in Non-Small Cell Lung Cancer.
    Dong J; Zhang RY; Sun N; Smalley M; Wu Z; Zhou A; Chou SJ; Jan YJ; Yang P; Bao L; Qi D; Tang X; Tseng P; Hua Y; Xu D; Kao R; Meng M; Zheng X; Liu Y; Vagner T; Chai X; Zhou D; Li M; Chiou SH; Zheng G; Di Vizio D; Agopian VG; Posadas E; Jonas SJ; Ju SP; Weiss PS; Zhao M; Tseng HR; Zhu Y
    ACS Appl Mater Interfaces; 2019 Apr; 11(15):13973-13983. PubMed ID: 30892008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of cytologic findings in neuroendocrine carcinomas including carcinoid tumors with histologic correlation.
    Nicholson SA; Ryan MR
    Cancer; 2000 Jun; 90(3):148-61. PubMed ID: 10896328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of the 1981 WHO histological classification in inter-observer reproducibility and changing pattern of lung cancer.
    Campobasso O; Andrion A; Ribotta M; Ronco G
    Int J Cancer; 1993 Jan; 53(2):205-8. PubMed ID: 8381110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What causes p53 mutations in patients with lung cancer?
    Sekine I; Shao GG; Fahey M; Kodama T; Nagai K; Kuriyama T
    Oncol Rep; 1998; 5(5):1125-8. PubMed ID: 9683821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical endocrine tumors of the lung: a histologic, ultrastructural, and clinical study of 19 cases.
    Neal MH; Kosinski R; Cohen P; Orenstein JM
    Hum Pathol; 1986 Dec; 17(12):1264-77. PubMed ID: 3025075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.